Cargando…
Microsatellite instability and chemosensitivity in solid tumours
The use of biomarkers that influence a targeted choice in cancer treatments is the future of medical oncology. Within this scenario, in recent years, an important role has been played by knowledge of microsatellite instability (MSI), a molecular fingerprint that identifies defects in the mismatch re...
Autores principales: | Cherri, Sara, Oneda, Ester, Noventa, Silvia, Melocchi, Laura, Zaniboni, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127927/ https://www.ncbi.nlm.nih.gov/pubmed/35620236 http://dx.doi.org/10.1177/17588359221099347 |
Ejemplares similares
-
Pancreatic adenocarcinoma: Beyond first line, where are we?
por: Cherri, Sara, et al.
Publicado: (2021) -
Optimizing the first-line treatment for metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2023) -
Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?
por: Cherri, Sara, et al.
Publicado: (2020) -
Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
por: Cherri, Sara, et al.
Publicado: (2023) -
Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature
por: Oneda, Ester, et al.
Publicado: (2019)